We're here to beat blood cancer
Blood Cancer UK (bloodwise.org.uk) scores 80 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Non-profit brands, Healthcare brands, in the 66th percentile of 7771 Non-profit brands.
Blood Cancer UK is a UK-based charity, founded in 1960 and headquartered in London, dedicated to beating all types of blood cancer, including leukaemia, lymphoma and myeloma. It funds scientific research and provides support services, information, and community forums for people affected by blood cancer, their families, healthcare professionals, and donors. The charity combines research funding with direct patient support and care, positioning itself as a community-driven organisation working toward better outcomes for blood cancer patients.
| Brand Name | Blood Cancer UK |
|---|---|
| Domain | bloodwise.org.uk |
| Industry | Non-profit, Healthcare |
| Founded | 1960 |
| Headquarters | London |
| Main Competitors | Cancer Research UK (91/100), Leukaemia UK (74/100), Myeloma UK, Lymphoma Action, Macmillan Cancer Support (87/100), DKMS |
Moz Domain Authority 59/100 vs category average 51 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,448,143 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Blood Cancer UK appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "Blood Cancer UK is a community dedicated to beating all types of blood cancer by funding research and supporting those affected." (Meta description: 21 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare.
Social footprint: verified profiles on Facebook, Instagram, X (Twitter), YouTube, LinkedIn, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Blood Cancer UK?", Claude could identify the brand as of September 2026. Blood Cancer UK is a British charity (formerly known as Bloodwise, and before that Leukaemia & Lymphoma Research) that funds research into blood cancers like leukaemia, lymphoma and myeloma, and provides support and information to patients and families. Best known for Funding blood cancer research and supporting patients in the UK, previously operating under the name Bloodwise.
When asked "Best brands similar to Blood Cancer UK?", Claude would recommend Blood Cancer UK as of September 2026. It's a well-established and reputable UK health charity focused specifically on blood cancer research and patient support, making it a natural recommendation in that space.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Blood Cancer UK's main competitors in Non-profit: Cancer Research UK (91/100), Leukaemia UK (74/100), Macmillan Cancer Support (87/100).
Sources: Brand Analyzer scan
Blood Cancer UK offers research funding for blood cancer studies, support services for patients and families affected by blood cancer, informational resources about leukaemia, lymphoma, myeloma and other blood cancers, and community forums that allow people to connect and share experiences. It also provides avenues for donors and supporters to contribute financially to its mission.
Sources: Blood Cancer UK official site
Blood Cancer UK is a UK-based charity founded in 1960 and headquartered in London. It is dedicated to beating all types of blood cancer, such as leukaemia, lymphoma and myeloma, by funding research and supporting those affected by the disease.
Sources: Blood Cancer UK official site
Blood Cancer UK has limited AI-search visibility, scoring 44/100 on Brand Analyzer's AI visibility composite (visibility 41, trust 29, recommendation 66). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Blood Cancer UK official site
Blood Cancer UK was founded in 1960. Blood Cancer UK operates in the Non-profit category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Blood Cancer UK is headquartered in London. Blood Cancer UK operates in the Non-profit category.
Sources: Wikidata
Blood Cancer UK funds scientific research into blood cancer and provides support services for people diagnosed with the disease, as well as their friends and family. It also offers community forums where patients and supporters can connect, share experiences, and access information, while engaging donors and healthcare professionals to further its mission.
Sources: Blood Cancer UK official site
Blood Cancer UK scores 66/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Non-profit options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Blood Cancer UK official site
Blood Cancer UK can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Blood Cancer UK official site
Blood Cancer UK is used by people diagnosed with blood cancer and their friends and family members seeking support and information. It is also used by healthcare professionals who may reference its resources, as well as donors and supporters who wish to fund blood cancer research and care initiatives.
Sources: Blood Cancer UK official site
Blood Cancer UK is known for its long-standing role as a UK charity focused specifically on blood cancers, combining research funding with direct patient and family support. It has built a community-driven approach that brings together scientific research efforts with practical care and forums for those affected by leukaemia, lymphoma, myeloma and related conditions.
Sources: Blood Cancer UK official site
Blood Cancer UK scores 44/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Blood Cancer UK has a limited AI-visibility profile at 44/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (66/100) and its weakest is trust (29/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,448,143 (Tranco) and a Moz Domain Authority of 59/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Blood Cancer UK from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Blood Cancer UK: Bitfocus (80/100), Bira (British Independent Retailers Association) (80/100), BlueOrchard (80/100), National Botanic Garden of Wales (80/100).
A step up - brands to learn from: Youth Ki Awaaz (81/100), Young Survival Coalition (81/100).
Category leader: Change.org (97/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.